CDC Restructuring Aims to Improve Timeliness and Accountability

Director Rochelle Walensky said the agency’s handling of the COVID-19 pandemic fell short and outlined plans to reorganize and strengthen its response to future public health threats.

Written byChristie Wilcox, PhD
| 2 min read
The David J. Sencer Museum at the headquarters of the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The US Centers for Disease Control and Prevention will soon undergo a restructuring, Director Rochelle Walensky announced to staff in an email Wednesday (August 17), according to multiple outlets.

“For 75 years, CDC and public health have been preparing for COVID-19, and in our big moment, our performance did not reliably meet expectations,” Walensky wrote in the email, which was sent to the agency’s more than 11,000 employees, reports STAT. “My goal is a new, public health action-oriented culture at CDC that emphasizes accountability, collaboration, communication, and timeliness.”

The Atlanta-based agency, whose mission includes protecting Americans from public health threats, has come under fire for repeated failures during the COVID-19 pandemic response, including distributing contaminated test kits and poor messaging early in the pandemic, and most recently, its ponderous response to the emergence of monkeypox. “We saw during COVID that CDC’s structures, frankly, weren’t designed to take in information, digest ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies